The lowdown on COVID-19 with Bhekisisa’s Mia Malan

Bhekisisa has been keeping the South African public up to date on a daily basis on all COVID-19 related issues. Editor-in-Chief Mia Malan gives up a round up on the vaccination strategy progress and the 3rd wave which is now upon us. She also gives us insight into how she is managing both her home and her workplace as the 3rd wave hits Gauteng.

Aspen annouces deal with Johnson & Johnson to manufacture investigational Covid-19 vaccine candidate

Aspen is working with Johnson & Johnson, for the proposed commercial manufacture of their COVID-19 vaccine candidate, Ad26.COV2-S. The vaccine candidate is currently undergoing clinical trials. Aspen Pharmacare has agreed to provide the necessary capacity required for the manufacture of Johnson & Johnson’s COVID-19 vaccine candidate at its existing sterile facility in Port Elizabeth, South Africa.